INCY
Price
$68.45
Change
+$0.28 (+0.41%)
Updated
Jul 3 closing price
Capitalization
13.25B
29 days until earnings call
KTTA
Price
$0.73
Change
-$0.02 (-2.67%)
Updated
Jul 3 closing price
Capitalization
5.45M
Interact to see
Advertisement

INCY vs KTTA

Header iconINCY vs KTTA Comparison
Open Charts INCY vs KTTABanner chart's image
Incyte
Price$68.45
Change+$0.28 (+0.41%)
Volume$1.27M
Capitalization13.25B
Pasithea Therapeutics
Price$0.73
Change-$0.02 (-2.67%)
Volume$67.1K
Capitalization5.45M
INCY vs KTTA Comparison Chart in %
Loading...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INCY vs. KTTA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCY is a Hold and KTTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (INCY: $68.45 vs. KTTA: $0.73)
Brand notoriety: INCY: Notable vs. KTTA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INCY: 64% vs. KTTA: 1%
Market capitalization -- INCY: $13.25B vs. KTTA: $5.45M
INCY [@Biotechnology] is valued at $13.25B. KTTA’s [@Biotechnology] market capitalization is $5.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCY’s FA Score shows that 1 FA rating(s) are green whileKTTA’s FA Score has 1 green FA rating(s).

  • INCY’s FA Score: 1 green, 4 red.
  • KTTA’s FA Score: 1 green, 4 red.
According to our system of comparison, INCY is a better buy in the long-term than KTTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCY’s TA Score shows that 4 TA indicator(s) are bullish while KTTA’s TA Score has 5 bullish TA indicator(s).

  • INCY’s TA Score: 4 bullish, 4 bearish.
  • KTTA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than INCY.

Price Growth

INCY (@Biotechnology) experienced а -3.33% price change this week, while KTTA (@Biotechnology) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

INCY is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCY($13.2B) has a higher market cap than KTTA($5.45M). INCY YTD gains are higher at: -0.898 vs. KTTA (-76.756). INCY has higher annual earnings (EBITDA): 407M vs. KTTA (-13.24M). INCY has more cash in the bank: 2.41B vs. KTTA (5.34M). KTTA has less debt than INCY: KTTA (0) vs INCY (43.1M). INCY has higher revenues than KTTA: INCY (4.41B) vs KTTA (0).
INCYKTTAINCY / KTTA
Capitalization13.2B5.45M242,202%
EBITDA407M-13.24M-3,074%
Gain YTD-0.898-76.7561%
P/E Ratio342.25N/A-
Revenue4.41B0-
Total Cash2.41B5.34M45,104%
Total Debt43.1M0-
FUNDAMENTALS RATINGS
INCY: Fundamental Ratings
INCY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INCYKTTA
RSI
ODDS (%)
Bearish Trend 5 days ago
63%
Bullish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bullish Trend 5 days ago
56%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
67%
Bullish Trend 5 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
64%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
59%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 28 days ago
60%
Bullish Trend 6 days ago
71%
Declines
ODDS (%)
Bearish Trend 8 days ago
62%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
73%
Bullish Trend 5 days ago
79%
Aroon
ODDS (%)
Bullish Trend 5 days ago
61%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AAPX20.450.15
+0.74%
T-Rex 2X Long Apple Daily Target ETF
CGMM27.470.17
+0.62%
Capital Group U.S. Small & Mid Cap ETF
BGR13.520.04
+0.30%
Blackrock Energy and Resources Trust
CWI32.820.09
+0.27%
SPDR® MSCI ACWI ex-US ETF
FLMB22.980.02
+0.09%
Franklin Municipal Green Bond ETF

INCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with TECH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
+0.41%
TECH - INCY
40%
Loosely correlated
-0.08%
AGIO - INCY
38%
Loosely correlated
+2.04%
REGN - INCY
38%
Loosely correlated
-0.07%
LGND - INCY
37%
Loosely correlated
+0.81%
RPRX - INCY
37%
Loosely correlated
+0.50%
More

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and INCY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and INCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-2.09%
INCY - KTTA
28%
Poorly correlated
+0.41%
SCNI - KTTA
26%
Poorly correlated
-2.95%
GNFT - KTTA
22%
Poorly correlated
+2.11%
TRAW - KTTA
22%
Poorly correlated
-0.68%
BPMC - KTTA
21%
Poorly correlated
+0.12%
More